Charting the Rise of Single Use

Single-use systems have come a long way. Timothy Korwan, Director of New Product Development, and Sean DeFusco, General Manager, from Avantor, discuss biopharma’s experience with the technology so far – and consider why it has become a popular choice for producing new drugs.

Take us back to the early days of single-use...

Timothy Korwan: During the late 90’s, I started working for a biotech company that relied heavily on stainless steel, but we slowly began introducing single-use technologies where we could see immediate benefits. – first in filtration to replace multi-use components in the transfer steps between tanks; we realized immediate benefits by removing cleaning steps and saw a faster turnaround for some applications. Over time, we began integrating single use for simple 2D and 3D bags, holding containers and for non-sterile application buffers.

Sean DeFusco: We’ve always been using single-use products in the industry; we just used to call them disposable products. For example, though they fit into a reusable metal housing, the filters themselves would be thrown out after one use. Items such as tubing tended to be single use as well. It was when we started combining these components into more sophisticated systems that single use took on the meaning it has today. There was early demand to integrate ready-to-use systems in stainless steel environments, but they required a device to mate with the stainless steel. That's when we saw the crossover begin, where single-use technology was introduced to a stainless steel system. As soon as those connectors were developed, uptake increased and the true benefits of single use began to be realized, making processes more efficient and cost-effective.

Read more


Authors

Sean DeFusco

General Manager of Avantor’s Single-Use Solutions

For over 20 years, Sean has held various sales and operational leadership roles in both the pharmaceutical and microelectronics industry, delivering high-quality products, services and solutions. Sean holds a Bachelor Degree in Chemical Engineering from the University of Rhode Island.

Timothy Korwan

Director of New Product Development at Avantor

Tim has 20+ years of experience as an engineer and business development with VWR, PAW BioScience Products, and Biopure Corporation where he has designed single-use products, components, and systems that are used by the global drug and vaccine manufacturing industry.

Solutions for bioprocessing

From the small-scale bench to full commercial manufacturing, we enable our customers to reach the market with new treatments for patients, faster and safer. Learn more about our offering for biopharmaceutical manufacturing.

Customer support

Contact us

Ready to streamline your bioprocessing manufacturing workflows? Avantor Biopharma Production can help.

Avantor®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. One of our greatest strengths comes from having a global infrastructure that is strategically located to support the needs of our customers. Our global footprint enables us to serve more than 225,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world.